Eli Lilly and Walmart Launch Retail Pickup for Zepbound

Eli Lilly and Walmart have announced a new partnership to provide easier access to the weight loss drug Zepbound. Starting midNovember, patients with a prescription can buy singledose vials at Walmart stores or through home delivery, with discounts of 50% or more from the list price. This initiative marks the first time Zepbound will be available at retail locations, enhancing access for U.S. patients. Eli Lilly aims to maintain its competitive edge over rival Novo Nordisk in the growing market for obesity and diabetes treatments. Patients will pay $349 for the starting dose and $499 for higher doses, whether picking up at Walmart or opting for home delivery. The partnership is part of Eli Lilly's strategy to enhance price transparency and convenience for consumers, aligning with governmental efforts to make healthcare more accessible. Overall, this collaboration is expected to significantly improve the availability of Zepbound across the country.